BIOMAT Database Logo BIOMAT Database Logo

Hemolysis after high-dose intravenous Ig. 1993

M J Thomas, and S A Misbah, and H M Chapel, and M Jones, and G Elrington, and J Newsom-Davis

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001788 Blood Grouping and Crossmatching Testing erythrocytes to determine presence or absence of blood-group antigens, testing of serum to determine the presence or absence of antibodies to these antigens, and selecting biocompatible blood by crossmatching samples from the donor against samples from the recipient. Crossmatching is performed prior to transfusion. Blood Typing,Crossmatching, Blood,Blood Grouping,Blood Crossmatching,Grouping, Blood,Typing, Blood
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015624 Lambert-Eaton Myasthenic Syndrome An autoimmune disease characterized by weakness and fatigability of proximal muscles, particularly of the pelvic girdle, lower extremities, trunk, and shoulder girdle. There is relative sparing of extraocular and bulbar muscles. CARCINOMA, SMALL CELL of the lung is a frequently associated condition, although other malignancies and autoimmune diseases may be associated. Muscular weakness results from impaired impulse transmission at the NEUROMUSCULAR JUNCTION. Presynaptic calcium channel dysfunction leads to a reduced amount of acetylcholine being released in response to stimulation of the nerve. (From Adams et al., Principles of Neurology, 6th ed, pp 1471) Eaton-Lambert Syndrome,Myasthenic Syndrome, Lambert-Eaton,Eaton-Lambert Myasthenic Syndrome,Lambert-Eaton Syndrome,Myasthenic-Myopathic Syndrome of Eaton-Lambert,Myasthenic-Myopathic Syndrome of Lambert-Eaton,Myopathic-Myasthenic Syndrome of Eaton-Lambert,Myopathic-Myasthenic Syndrome of Lambert-Eaton,Eaton Lambert Myasthenic Syndrome,Eaton Lambert Syndrome,Eaton-Lambert Myasthenic-Myopathic Syndrome,Eaton-Lambert Myopathic-Myasthenic Syndrome,Eaton-Lambert Myopathic-Myasthenic Syndromes,Lambert Eaton Myasthenic Syndrome,Lambert Eaton Syndrome,Lambert-Eaton Myasthenic-Myopathic Syndrome,Lambert-Eaton Myasthenic-Myopathic Syndromes,Lambert-Eaton Myopathic-Myasthenic Syndrome,Lambert-Eaton Myopathic-Myasthenic Syndromes,Myasthenic Myopathic Syndrome of Eaton Lambert,Myasthenic Myopathic Syndrome of Lambert Eaton,Myasthenic Syndrome, Eaton-Lambert,Myasthenic Syndrome, Lambert Eaton,Myopathic Myasthenic Syndrome of Eaton Lambert,Syndrome, Eaton-Lambert,Syndrome, Eaton-Lambert Myasthenic,Syndrome, Lambert-Eaton,Syndrome, Lambert-Eaton Myasthenic
D016756 Immunoglobulins, Intravenous Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA. Antibodies, Intravenous,Human Intravenous Immunoglobulin,IV Immunoglobulin,IVIG,Intravenous Antibodies,Intravenous Immunoglobulin,Intravenous Immunoglobulins,Alphaglobin,Endobulin,Flebogamma DIF,Gamimmune,Gamimmune N,Gamimune,Gamimune N,Gammagard,Gammonativ,Gamunex,Globulin-N,IV Immunoglobulins,Immune Globulin Intravenous (Human),Immune Globulin, Intravenous,Immunoglobulins, Intravenous, Human,Intraglobin,Intraglobin F,Intravenous IG,Intravenous Immunoglobulins, Human,Iveegam,Modified Immune Globulin (Anti-Echovirus Antibody),Privigen,Sandoglobulin,Venimmune,Venoglobulin,Venoglobulin-I,Globulin N,Human Intravenous Immunoglobulins,Immunoglobulin, Human Intravenous,Immunoglobulin, IV,Immunoglobulin, Intravenous,Immunoglobulins, Human Intravenous,Immunoglobulins, IV,Intravenous Immune Globulin,Intravenous Immunoglobulin, Human,Venoglobulin I

Related Publications

M J Thomas, and S A Misbah, and H M Chapel, and M Jones, and G Elrington, and J Newsom-Davis
Hemolysis after high-dose intravenous immunoglobulin: An under-appreciated sequelae.
May 2022, American journal of hematology,
M J Thomas, and S A Misbah, and H M Chapel, and M Jones, and G Elrington, and J Newsom-Davis
Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patients.
December 2009, Clinical journal of the American Society of Nephrology : CJASN,
M J Thomas, and S A Misbah, and H M Chapel, and M Jones, and G Elrington, and J Newsom-Davis
Hemolysis after administration of high-dose fentanyl.
February 1986, Anesthesia and analgesia,
M J Thomas, and S A Misbah, and H M Chapel, and M Jones, and G Elrington, and J Newsom-Davis
Bradycardia after high-dose intravenous methylprednisolone therapy.
January 1986, Scandinavian journal of rheumatology,
M J Thomas, and S A Misbah, and H M Chapel, and M Jones, and G Elrington, and J Newsom-Davis
Hemolysis due to high-dose intravenous gammaglobulin treatment for patients with idiopathic thrombocytopenic purpura.
January 1986, Acta haematologica,
M J Thomas, and S A Misbah, and H M Chapel, and M Jones, and G Elrington, and J Newsom-Davis
Treatment of epidermal necrolysis with high-dose intravenous immunoglobulins (IV Ig): clinical experience to date.
January 2005, Drugs,
M J Thomas, and S A Misbah, and H M Chapel, and M Jones, and G Elrington, and J Newsom-Davis
Fatal hemolysis after high-dose etoposide: is benzyl alcohol to blame?
June 2001, Pharmacotherapy,
M J Thomas, and S A Misbah, and H M Chapel, and M Jones, and G Elrington, and J Newsom-Davis
Platelet kinetics after high dose intravenous gamma globulin.
July 1984, Thrombosis and haemostasis,
M J Thomas, and S A Misbah, and H M Chapel, and M Jones, and G Elrington, and J Newsom-Davis
Chronic hepatitis C after high-dose intravenous immunoglobulin.
January 1994, Transfusion,
M J Thomas, and S A Misbah, and H M Chapel, and M Jones, and G Elrington, and J Newsom-Davis
Letter: Acute arthralgia after high-dose intravenous methylprednisolone.
November 1974, Lancet (London, England),
Copied contents to your clipboard!